The Centers for Medicare and Medicaid Services has shared a final notice for a new pathway to cover breakthrough medical devices. The pathway, called Transitional Coverage for Emerging Technologies (TCET), is intended to expedite Medicare coverage of new medical devices. On average, it takes about five years after a device is authorized by the Food and Drug Administration to gain national Medicare and commercial insurance coverage, according to a survey by the Stanford Byers Center for Biodesign.
Read the full article: CMS Finalizes Notice on Medicare Coverage for Breakthrough Devices //
Source: https://www.medtechdive.com/news/cms-finalizes-breakthrough-device-coverage-tcet/723713/